Recent findings suggest CT scans could be a major cancer risk, but some critics don’t think the estimates add up.

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer scans.

A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

CHICAGO (Reuters) - The same type of scanner used to peer into the body to detect cancers will be put to an even more delicate use -- checking on the viability of the nation's aging nuclear stockpile, ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Ozempic and other weight loss jabs have recently gained a lot of fame, as people rush to buy and use them. However, many ...